Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
gHsUdpAEENZJ7gLu
